Aryl hydrocarbon receptor deficiency augments dysregulated microangiogenesis and diabetic retinopathy

Wen Jane Lee, Keng Hung Lin, Jun Sing Wang, Wayne Huey Herng Sheu, Chin Chang Shen, Cheng Ning Yang, Sheng Mao Wu, Li Wei Shen, Shu Hua Lee, De Wei Lai, Keng Li Lan, Chun Wei Tung, Shing Hwa Liu, Meei Ling Sheu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Diabetic retinopathy (DR) is a pathophysiologic vasculopathic process with obscure mechanisms and limited effective therapeutic strategies. Aryl hydrocarbon receptor (AhR) is an important regulator of xenobiotic metabolism and an environmental sensor. The aim of the present study was to investigate the role of AhR in the development of DR and elucidate the molecular mechanism of its downregulation. DR was evaluated in diabetes-induced retinal injury in wild type and AhR knockout (AhR-/-) mice. Retinal expression of AhR was determined in human donor and mice eyes by immunofluorescence since AhR activity was examined in diabetes. AhR knockout (AhRKO) mice were used to induce diabetes with streptozotocin, high-fat diet, or genetic double knockout with diabetes spontaneous mutation (Leprdb) (DKO; AhR-/-×Leprdb/db) for investigating structural, functional, and metabolic abnormalities in vascular and epithelial retina. Structural molecular docking simulation was used to survey the pharmacologic AhR agonists targeting phosphorylated AhR (Tyr245). Compared to diabetic control mice, diabetic AhRKO mice had aggravated alterations in retinal vasculature that amplified hallmark features of DR like vasopermeability, vascular leakage, inflammation, blood-retinal barrier breakdown, capillary degeneration, and neovascularization. AhR agonists effectively inhibited inflammasome formation and promoted AhR activity in human retinal microvascular endothelial cells and pigment epithelial cells. AhR activity and protein expression was downregulated, resulting in a decrease in DNA promoter binding site of pigment epithelium-derived factor (PEDF) by gene regulation in transcriptional cascade. This was reversed by AhR agonists. Our study identified a novel of DR model that target the protective AhR/PEDF axis can potentially maintain retinal vascular homeostasis, providing opportunities to delay the development of DR.

Original languageEnglish
Article number113725
JournalBiomedicine and Pharmacotherapy
StatePublished - Nov 2022


  • Aryl hydrocarbon receptor
  • Diabetic retinopathy
  • Inflammasome
  • Pigment epithelium-derived factor


Dive into the research topics of 'Aryl hydrocarbon receptor deficiency augments dysregulated microangiogenesis and diabetic retinopathy'. Together they form a unique fingerprint.

Cite this